ARTEMETIN-BETA

This brand name is authorized in Nigeria.

Active ingredients

The drug ARTEMETIN-BETA contains one active pharmaceutical ingredient (API):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5947	Injection	ARTEMETIN-BETA INJECTION INJ 80 mg/mL 1mlx6	60 RNW-PP-313291 ARTEMETIN-BETA INJECTION ARTEMETHER 80MG/ML Artemether 80mg/ml Tea-seed oil q.s to 1ml A4-5947 Drugs Imported Products 1mlx6 Prescription Only Medicine (POM) 2/9/2023 LABETA DRUGS LIMITED, NO 125C OLAITAN STREET, OFF NNOBI STREET, SURULERE LAGOS 18544878 greenabeta_nig@yahoo.com ANHUI CHENGSHI PHARMACEUTICAL CO,. LTD, NO. 5068 HUAISHANG ROAD, BENGBU, ANHUI PROVINCE . CHINA, China	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BE02	Artemether	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BE Artemisinin and derivatives
Discover more medicines within P01BE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5947